Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors.

Saved in:
Bibliographic Details
Title: Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors.
Authors: Hoots, W. K.1,2 keith.hoots@uth.tmc.edu, Ebbesen, L. S.3, Konkle, B. A.4, Auerswald, G. K.-H.5, Roberts, H. R.6, Weatherall, J.3, Ferran, J.-M.3, Ljung, R. C. R.7
Source: Haemophilia. May2008, Vol. 14 Issue 3, p466-475. 10p. 3 Charts, 3 Graphs.
Database: Academic Search Ultimate
Description
ISSN:13518216
DOI:10.1111/j.1365-2516.2008.01654.x